Covered recipient · General Payments record
CYNTHIA MA
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2024
$55,658.27
- Reported across 88 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,666.00 | 6 |
| Food and Beverage | $475.78 | 6 |
| Honoraria | $37.15 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Eli Lilly and Company | $1,441.55 | 4 |
| AstraZeneca UK Limited | $666.00 | 2 |
| Acerta Pharma LLC | $600.00 | 1 |
| Stemline Therapeutics Inc. | $292.80 | 3 |
| MENARINI SILICON BIOSYSTEMS, INC. | $84.08 | 1 |
| Exelixis Inc. | $75.00 | 1 |
| PFIZER INC. | $19.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $600.00 | 11/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110534944 | CMS |
| AstraZeneca UK Limited | $366.00 | 04/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110531159 | CMS |
| AstraZeneca UK Limited | $300.00 | 11/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110535522 | CMS |
| Eli Lilly and Company | $700.00 | 01/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136123220 | CMS |
| Eli Lilly and Company | $350.00 | 06/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136134577 | CMS |
| Eli Lilly and Company | $350.00 | 11/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136115478 | CMS |
| Eli Lilly and Company | $41.55 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136137078 | CMS |
| Exelixis Inc. | $75.00 | 10/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138556569 | CMS |
| Menarini Silicon Biosystems, Inc. | $84.08 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107214603 | CMS |
| PFIZER INC. | $19.50 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131598745 | CMS |
| Stemline Therapeutics Inc. | $137.72 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142959146 | CMS |
| Stemline Therapeutics Inc. | $37.15 | 06/28/2024 | Honoraria | Undisputed | 01/23/2026 | 1142959144 | CMS |
| Stemline Therapeutics Inc. | $117.93 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142959148 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.